Search Results - "Viscosi, E."

Swallowing Function After Proton Beam Therapy for Nasopharyngeal Cancer: A Prospective Study by Goldsmith, T, Holman, A.S, Parambi, R.J, Weyman, E, Busse, P.M, Viscosi, E, Wirth, L.J, Clark, J.R, Rothenberg, S.M, Chan, A.W

Get full text

358TiP Phase Ib/II study of antibody-drug conjugate, sacituzumab govitecan, in combination with the PARP inhibitor, talazoparib, in metastatic triple-negative breast cancer by Bardia, A., Spring, L.M., Juric, D., Partridge, A., Ligibel, J., Kuter, I., Peppercorn, J., Parsons, H., Ryan, P., Chawla, D., Attaya, V., Fitzgerald, D.M., Viscosi, E., Lormill, B., Shellock, M., Moy, B., Tolaney, S.M., Ellisen, L.W.

Get full text

Phase II Trial of Thalidomide and Carmustine for Patients With Recurrent High-Grade Gliomas by FINE, Howard A, WEN, Patrick Y, MAHER, Elizabeth A, VISCOSI, Elene, BATCHELOR, Tracy, LAKHANI, Nehal, FIGG, William D, PUROW, Benjamin W, BORKOWF, Craig B

“…The use of thalidomide as an antiangiogenic agent has met with only limited success in the treatment of malignant gliomas. On the basis of preclinical data…”
Get full text